代谢 "极不健康 "的肥胖和非肥胖糖尿病患者与心血管不良事件的风险:西里西亚糖尿病-心脏项目。

IF 8.5 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Oliwia Janota, Marta Mantovani, Hanna Kwiendacz, Krzysztof Irlik, Tommaso Bucci, Steven H M Lam, Bi Huang, Uazman Alam, Giuseppe Boriani, Mirela Hendel, Julia Piaśnik, Anna Olejarz, Aleksandra Włosowicz, Patrycja Pabis, Wiktoria Wójcik, Janusz Gumprecht, Gregory Y H Lip, Katarzyna Nabrdalik
{"title":"代谢 \"极不健康 \"的肥胖和非肥胖糖尿病患者与心血管不良事件的风险:西里西亚糖尿病-心脏项目。","authors":"Oliwia Janota, Marta Mantovani, Hanna Kwiendacz, Krzysztof Irlik, Tommaso Bucci, Steven H M Lam, Bi Huang, Uazman Alam, Giuseppe Boriani, Mirela Hendel, Julia Piaśnik, Anna Olejarz, Aleksandra Włosowicz, Patrycja Pabis, Wiktoria Wójcik, Janusz Gumprecht, Gregory Y H Lip, Katarzyna Nabrdalik","doi":"10.1186/s12933-024-02420-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is a growing burden of non-obese people with diabetes mellitus (DM). However, their cardiovascular risk (CV), especially in the presence of cardiovascular-kidney-metabolic (CKM) comorbidities is poorly characterised. The aim of this study was to analyse the risk of major CV adverse events in people with DM according to the presence of obesity and comorbidities (hypertension, chronic kidney disease, and dyslipidaemia).</p><p><strong>Methods: </strong>We analysed persons who were enrolled in the prospective Silesia Diabetes Heart Project (NCT05626413). Individuals were divided into 6 categories according to the presence of different clinical risk factors (obesity and CKM comorbidities): (i) Group 1: non-obese with 0 CKM comorbidities; (ii) Group 2: non-obese with 1-2 CKM comorbidities; (iii) Group 3: non-obese with 3 CKM comorbidities (non-obese \"extremely unhealthy\"); (iv) Group 4: obese with 0 CKM comorbidities; (v) Group 5: obese with 1-2 CKM comorbidities; and (vi) Group 6: obese with 3 CKM comorbidities (obese \"extremely unhealthy\"). The primary outcome was a composite of CV death, myocardial infarction (MI), new onset of heart failure (HF), and ischemic stroke.</p><p><strong>Results: </strong>2105 people with DM were included [median age 60 (IQR 45-70), 48.8% females]. Both Group 1 and Group 6 were associated with a higher risk of events of the primary composite outcome (aHR 4.50, 95% CI 1.20-16.88; and aHR 3.78, 95% CI 1.06-13.47, respectively). On interaction analysis, in \"extremely unhealthy\" persons the impact of CKM comorbidities in determining the risk of adverse events was consistent in obese and non-obese ones (P<sub>int</sub>=0.824), but more pronounced in individuals aged < 65 years compared to older adults (P<sub>int</sub>= 0.028).</p><p><strong>Conclusion: </strong>Both non-obese and obese people with DM and 3 associated CKM comorbidities represent an \"extremely unhealthy\" phenotype which are at the highest risk of CV adverse events. These results highlight the importance of risk stratification of people with DM for risk factor management utilising an interdisciplinary approach.</p>","PeriodicalId":9374,"journal":{"name":"Cardiovascular Diabetology","volume":null,"pages":null},"PeriodicalIF":8.5000,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373332/pdf/","citationCount":"0","resultStr":"{\"title\":\"Metabolically \\\"extremely unhealthy\\\" obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project.\",\"authors\":\"Oliwia Janota, Marta Mantovani, Hanna Kwiendacz, Krzysztof Irlik, Tommaso Bucci, Steven H M Lam, Bi Huang, Uazman Alam, Giuseppe Boriani, Mirela Hendel, Julia Piaśnik, Anna Olejarz, Aleksandra Włosowicz, Patrycja Pabis, Wiktoria Wójcik, Janusz Gumprecht, Gregory Y H Lip, Katarzyna Nabrdalik\",\"doi\":\"10.1186/s12933-024-02420-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>There is a growing burden of non-obese people with diabetes mellitus (DM). However, their cardiovascular risk (CV), especially in the presence of cardiovascular-kidney-metabolic (CKM) comorbidities is poorly characterised. The aim of this study was to analyse the risk of major CV adverse events in people with DM according to the presence of obesity and comorbidities (hypertension, chronic kidney disease, and dyslipidaemia).</p><p><strong>Methods: </strong>We analysed persons who were enrolled in the prospective Silesia Diabetes Heart Project (NCT05626413). Individuals were divided into 6 categories according to the presence of different clinical risk factors (obesity and CKM comorbidities): (i) Group 1: non-obese with 0 CKM comorbidities; (ii) Group 2: non-obese with 1-2 CKM comorbidities; (iii) Group 3: non-obese with 3 CKM comorbidities (non-obese \\\"extremely unhealthy\\\"); (iv) Group 4: obese with 0 CKM comorbidities; (v) Group 5: obese with 1-2 CKM comorbidities; and (vi) Group 6: obese with 3 CKM comorbidities (obese \\\"extremely unhealthy\\\"). The primary outcome was a composite of CV death, myocardial infarction (MI), new onset of heart failure (HF), and ischemic stroke.</p><p><strong>Results: </strong>2105 people with DM were included [median age 60 (IQR 45-70), 48.8% females]. Both Group 1 and Group 6 were associated with a higher risk of events of the primary composite outcome (aHR 4.50, 95% CI 1.20-16.88; and aHR 3.78, 95% CI 1.06-13.47, respectively). On interaction analysis, in \\\"extremely unhealthy\\\" persons the impact of CKM comorbidities in determining the risk of adverse events was consistent in obese and non-obese ones (P<sub>int</sub>=0.824), but more pronounced in individuals aged < 65 years compared to older adults (P<sub>int</sub>= 0.028).</p><p><strong>Conclusion: </strong>Both non-obese and obese people with DM and 3 associated CKM comorbidities represent an \\\"extremely unhealthy\\\" phenotype which are at the highest risk of CV adverse events. These results highlight the importance of risk stratification of people with DM for risk factor management utilising an interdisciplinary approach.</p>\",\"PeriodicalId\":9374,\"journal\":{\"name\":\"Cardiovascular Diabetology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":8.5000,\"publicationDate\":\"2024-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373332/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Diabetology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12933-024-02420-x\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Diabetology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12933-024-02420-x","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:非肥胖糖尿病(DM)患者越来越多。然而,他们的心血管风险(CV),尤其是合并心血管-肾脏-代谢(CKM)疾病时的心血管风险,却鲜为人知。本研究旨在根据肥胖和合并症(高血压、慢性肾病和血脂异常)的存在情况,分析糖尿病患者发生重大心血管不良事件的风险:我们分析了参加前瞻性西里西亚糖尿病心脏项目(NCT05626413)的人员。根据是否存在不同的临床风险因素(肥胖和慢性肾脏病合并症),这些人被分为 6 个类别:(i) 第 1 组:非肥胖,无 CKM 合并症;(ii) 第 2 组:非肥胖,有 1-2 个 CKM 合并症;(iii) 第 3 组:非肥胖,有 3 个 CKM 合并症(非肥胖 "极不健康");(iv) 第 4 组:(v) 第 5 组:有 1-2 项 CKM 合并症的肥胖者;以及 (vi) 第 6 组:有 3 项 CKM 合并症的肥胖者(肥胖者 "极不健康")。主要结果是冠心病死亡、心肌梗死、新发心力衰竭和缺血性脑卒中的综合结果。结果:2105 名糖尿病患者被纳入研究[中位年龄 60 岁(IQR 45-70),48.8% 为女性]。第 1 组和第 6 组发生主要综合结果的风险较高(aHR 4.50,95% CI 1.20-16.88;aHR 3.78,95% CI 1.06-13.47)。交互分析显示,在 "极度不健康 "人群中,肥胖和非肥胖人群的慢性肾功能不全并发症对不良事件风险的影响是一致的(Pint=0.824),但在高龄人群中更为明显(Pint=0.028):结论:非肥胖和肥胖的糖尿病患者以及患有 3 种相关慢性肾功能不全并发症的患者都是 "极度不健康 "的表型,发生心血管不良事件的风险最高。这些结果凸显了利用跨学科方法对糖尿病患者进行风险分层以进行风险因素管理的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Metabolically "extremely unhealthy" obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project.

Background: There is a growing burden of non-obese people with diabetes mellitus (DM). However, their cardiovascular risk (CV), especially in the presence of cardiovascular-kidney-metabolic (CKM) comorbidities is poorly characterised. The aim of this study was to analyse the risk of major CV adverse events in people with DM according to the presence of obesity and comorbidities (hypertension, chronic kidney disease, and dyslipidaemia).

Methods: We analysed persons who were enrolled in the prospective Silesia Diabetes Heart Project (NCT05626413). Individuals were divided into 6 categories according to the presence of different clinical risk factors (obesity and CKM comorbidities): (i) Group 1: non-obese with 0 CKM comorbidities; (ii) Group 2: non-obese with 1-2 CKM comorbidities; (iii) Group 3: non-obese with 3 CKM comorbidities (non-obese "extremely unhealthy"); (iv) Group 4: obese with 0 CKM comorbidities; (v) Group 5: obese with 1-2 CKM comorbidities; and (vi) Group 6: obese with 3 CKM comorbidities (obese "extremely unhealthy"). The primary outcome was a composite of CV death, myocardial infarction (MI), new onset of heart failure (HF), and ischemic stroke.

Results: 2105 people with DM were included [median age 60 (IQR 45-70), 48.8% females]. Both Group 1 and Group 6 were associated with a higher risk of events of the primary composite outcome (aHR 4.50, 95% CI 1.20-16.88; and aHR 3.78, 95% CI 1.06-13.47, respectively). On interaction analysis, in "extremely unhealthy" persons the impact of CKM comorbidities in determining the risk of adverse events was consistent in obese and non-obese ones (Pint=0.824), but more pronounced in individuals aged < 65 years compared to older adults (Pint= 0.028).

Conclusion: Both non-obese and obese people with DM and 3 associated CKM comorbidities represent an "extremely unhealthy" phenotype which are at the highest risk of CV adverse events. These results highlight the importance of risk stratification of people with DM for risk factor management utilising an interdisciplinary approach.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cardiovascular Diabetology
Cardiovascular Diabetology 医学-内分泌学与代谢
CiteScore
12.30
自引率
15.10%
发文量
240
审稿时长
1 months
期刊介绍: Cardiovascular Diabetology is a journal that welcomes manuscripts exploring various aspects of the relationship between diabetes, cardiovascular health, and the metabolic syndrome. We invite submissions related to clinical studies, genetic investigations, experimental research, pharmacological studies, epidemiological analyses, and molecular biology research in this field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信